RankAlpha logo
Back to Rankings

GENB

Generate BiomedicinesB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
GENB vs peer average
68/100
GENB vs. peer average (B vs. C)
Grade spread
A 1 · B 3 · C 2 · D 2 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

AGIO is the first available peer comparator.

Clinical-stage biotech peer with valuation driven by pipeline execution and milestone timing rather than current earnings power; useful for comparing how investors price binary development progress.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerAGIOAgios
GENB
Generate Biomedicines
AGIO
Agios
Grade
B
F
Momentum
71
35
Value
46
41
Sentiment
68
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs AGIO

GENB / AGIO
Grade Position
In line
GENB vs. peer average (B vs. C)
68/100
Momentum
71
GENB
Value
46
GENB
Sentiment
68
GENB

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs GENB
1
AGIO
AGIO
F
20/100
+3
2
OCUL
OCUL
B
80/100
Even
3
PVLA
PVLA
D
40/100
+2
4
TSHA
Taysha Gene Therapies Inc Common
C
60/100
+1
5
AUPH
Aurinia Pharmaceuticals Inc Common
B
80/100
Even
AGIO is the first peer returned for this comparison set.